Andrea Ludwig-Sengpiel

FULFIL Trial: Once-Daily Triple Therapy for Patients with Chronic Obstructive Pulmonary Disease

David A. Lipson, Helen Barnacle, Ruby Birk et al. · American Journal of Respiratory and Critical Care Medicine · 2017 · 330 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects

Olaf Holz, Sauzanne Khalilieh, Andrea Ludwig-Sengpiel et al. · European Respiratory Journal · 2009 · 184 citations · Full text

Medicine, Immunology, Pharmacology +17

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

Andrew Menzies‐Gow, Michael E. Wechsler, Christopher E. Brightling et al. · The Lancet Respiratory Medicine · 2023 · 141 citations · Full text

Life Sciences, Immunology, Internal Medicine +13

Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients

Philip E. Silkoff, Michel Laviolette, Dave Singh et al. · Journal of Allergy and Clinical Immunology · 2017 · 69 citations

Life Sciences, Immunology, Inflammation +15

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study

Philip E. Silkoff, Irina Strâmbu, Michel Laviolette et al. · Respiratory Research · 2015 · 64 citations · Full text

Medicine, Internal Medicine, Molecular Medicine +14